The elevating incidence rate of autoimmune diseases across the globe and the growing number of researches on autoimmune disease diagnosis are boosting the market demand.
Market Size – USD 3.76 billion in 2019, Market Growth – CAGR of 8.7%, Market trends –Advancement in technology.
The global Autoimmune Disease Diagnosis Market is forecast to reach USD 7.37 Billion by 2027, according to a new report by Reports and Data. An increase in awareness of the autoimmune disease through education, research, and advocacy will drive the market demand.
A condition in which one’s immune system mistakenly attacks your body, it is known as an autoimmune disease. Normally, the immune system generally guards the body against foreign invaders, but when one has this disease, the immune system mistakes a part of the body as foreign and starts attacking healthy cells.
Multiple Sclerosis is a disabling condition of the central nervous system that impairs the flow of information within the brain and between the body and the brain. Increasing research related to the signs and treatments related to the disease is expected to drive the market growth. Another challenge faced by the Multiple Sclerosis therapeutics market is the lack of awareness among the people associated with the Multiple Sclerosis condition. The demand for Multiple Sclerosis is expected to increase owing to the new drug developments for treating Multiple Sclerosis, which in turn will drive the demand for the autoimmune disease diagnosis market.
Key participants include Siemens, Danaher, Thermo Fisher Scientific, Grifols, Abbott, Bio-Rad Laboratories, Werfen, Trinity Biotech, Hycor Biomedical, and Euroimmun, among others.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3436
Further key findings from the report suggest
- Consumables and Assay Kits dominated the market for autoimmune disease diagnostic and is forecasted to grow with a CAGR of 8.2% during the forecast period. The segment is driven by an increasing need for rapid diagnosis of autoimmune disease.
- Rheumatoid arthritis is an inflammatory disease that affects the joints. The condition worsens over time unless the inflammation is slowed or stopped. The disease rarely goes into remission without treatment. Statistics show that out of every 100,000 people, 41 are diagnosed with RA every year. Women are about 2-3 times more likely to get RA than men. Hormones in both genders may play a role in either preventing or triggering it.
- Hospital pharmacies are expected to hold a larger market share owing to an increase in the autoimmune disease consultations in clinics and hospitals. The prolonged use of these medications can lead to drug resistance, which compels the patients to refer to a rheumatologist and follow guided therapies. Moreover, the number of OTC Drugs available for treatment is insufficient, which, in turn, is further propelling the growth of this segment.
- The market in Asia-Pacific is anticipated to witness high growth during the forecast period owing to the increasing healthcare expenditure. Furthermore, the low cost of manufacturing in India and China has resulted in an increase in the production facilities, which attracts pharmaceutical and biotechnological giants to the region.
To identify the key trends in the industry, click on the link below: @ https://www.reportsanddata.com/report-detail/autoimmune-disease-diagnosis-market
For the purpose of this report, Reports and Data have segmented the global Autoimmune Disease Diagnosis Market on the basis of Product, Test Type, Disease, End User, and region:
Product Outlook (Revenue, USD Billion; 2017-2027)
- Instruments
- Consumables and Assay Kits
Test Type Outlook (Revenue, USD Billion; 2017-2027)
- Inflammatory markers
- Routine laboratory tests
- Autoantibodies and immunologic tests
- Others tests
Disease Outlook (Revenue, USD Billion; 2017-2027)
- Systemic Lupus Erythematosus
- Thyroiditis
- Rheumatoid Arthritis
- Sjögren’s Syndrome
- Scleroderma
- Others
End-User Outlook (Revenue, USD Billion; 2017-2027)
- Hospitals
- Clinical Laboratories
- Other
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- U.S
- Canada
- Europe
- Germany
- U.K
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- MEA
- Saudi Arabia
- UAE
- Rest of MEA
Order Now: @ https://www.reportsanddata.com/checkout-form/3436
Table of Content:
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Indicative Metrics
Chapter 4. Autoimmune Disease Diagnosis Market Segmentation & Impact Analysis
4.1. Autoimmune Disease Diagnosis Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Growing awareness for autoimmune diseases
4.2.2.2. High prevalence for autoimmune disease
4.2.3. Market restraints analysis
4.2.3.1. High capital requirement
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter’s Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price trend Analysis
4.9. Customer Mapping
4.10. Covid-19 Impact Analysis
4.11. Global Recession Influence
…
Chapter 10. Competitive Landscape
10.1. Market Revenue Share By Manufacturers
10.2. Manufacturing Cost Breakdown Analysis
10.3. Mergers & Acquisitions
10.4. Market positioning
10.5. Strategy Benchmarking
10.6. Vendor Landscape
Chapter 11. Company Profiles
11.1. Siemens
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Technology Insights
11.1.4. Strategic Initiatives
11.2. Danaher
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Technology Insights
11.2.4. Strategic Initiatives
11.3. Thermo Fisher Scientific
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Technology Insights
11.3.4. Strategic Initiatives
11.4. Grifols
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Technology Insights
11.4.4. Strategic Initiatives
11.5. Abbott
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Technology Insights
11.5.4. Strategic Initiatives
11.6. Bio Rad Laboratories
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Technology Insights
11.6.4. Strategic Initiatives
Continue….
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/press-release/global-autoimmune-disease-diagnosis-market